Jan 10, 2019 Rituximab shows disability benefits in patients with secondary progressive MS Rituximab shows disability benefits in patients with secondary progressive MS... sclerosis are limited; however, these findings suggest that B-cell–depleting therapy may be beneficial”, say the researchers in JAMA Neurology. ... read morePublished on 2019-01-10